Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCN-01 in Metastatic Melanoma
NCT00072189Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Nov 2003
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 7-hydroxystaurosporine in melanoma, sponsored by National Cancer Institute. Started Nov 2003; status: terminated.
02
Drugs
7-hydroxystaurosporine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00072189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072189.